Seizalam® (midazolam hydrochloride injection)

Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults and FDA approved for people exposed to chemicals that cause prolonged seizures.

Notify me on updates of this product 

Availability: Commercially Available

+1 800 638 8093
6350 Stevens Forest Road, Suite #301
Columbia, MD 21046
USA
www.meridianmeds.com
Manufacturer
Meridian Medical Technologies, Inc.
Product Name
Seizalam® (midazolam hydrochloride injection)
Detection Category
Chemical
Detection Method
Medical Countermeasure
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults and FDA approved for people exposed to chemicals that cause prolonged seizures.
Availability
Commercially Available
Technology Readiness Level (TRL)
9
Market Entry Date
2018
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Power Requirements
None
Transportability
Pocket Size
Live Agent Tested
Yes
Material
50 mg/10 mL (5 mg/mL) of a sterile, clear, colorless to light yellow liquid solution in a multiple-dose vial.
Operating Time
Immediate post-exposure use
Standards Met
FDA
Other Operational Parameters
Seizalam is for intramuscular use only. Inject in the mid-outer thigh (vastus lateralis muscle).
Training Required
<1 hour training
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: